We thank our Conference Speakers for their excellent contribution.
Interested in our Program Committee as well? Check out this link
This overview – in alphabetical order – lists invited speakers who have confirmed or yet have to confirm. The Conference Program and Speakers Overview can be subject to change.
Susanne Arbogast
Head Innovation & External Affairs Roche Diagnostics, Germany
Jurg de Beijer
Entrepreneur, author, speaker, co-founder of DRIVE – the core of change, the Netherlands
Maarten den Braber
Co-founder Quantified Self Europe, Advisory board member Dutch National Policy project ‘Quantified Health’ Rathenau Institute, the Netherlands; Quantified Self Europe
Stef van Buuren
Professor of Applied Statistics in Prevention, Netherlands Organization for Applied Scientific Research (TNO), Utrecht University, the Netherlands
Edwin Cuppen
Professor of Genome Biology, Professor of Human Genetics, UMC Utrecht, Hubrecht Institute, Developmental Biology and Stem Cell Research, the Netherlands.
Peter Dunki Jacobs
Peter B. Dunki Jacobs, MD.PhD, surgeon, Senior Consultant Quality & Innovation Zilveren Kruis Achmea, the Netherlands
Samir El Awadi
Commercial Director, Thales Nederland, the Netherlands
Pepijn van Empelen
Social psychologist, senior scientist Netherlands Organisation for Applied Scientific Research (TNO), Research Group Life Style, the Netherlands
Oscar Franco
Professor in Preventive Medicine, Principal Investigator Cardiovascular Epidemiology Group Erasmus MC, Founder and Director ErasmusAGE, Deputy Sciences Director Netherlands Institute for Health Sciences (NIHES), the Netherlands
Imke van Gasselt
Sr. Marketing Manager Responsible Retailing Albert Heijn, the Netherlands
Teun van Gelder
Professor in Clinical Pharmacology, Internist-nephrologist and clinical pharmacologist in Departments of Hospital Pharmacy and Internal Medicine Erasmus MC; Chairman of the Dutch Society for Clinical Pharmacology & Biopharmacy; Secretary of the Dutch Society for Transplantation, the Netherlands
Anna Göjeryd Ulander
Sektionschef Värdebaserad Vård / Value Based Health Care, Karolinska University Hospital, Sweden
Andrew Goldberg
Professor in Medicine, Director of the Baltimore VA Geriatric Research, Education and Clinical Center, the UMSOM Claude Pepper Older Americans Independence Center, UMSOM Division of Gerontology and Geriatric Medicine, the Center for Research on Aging and NIA training program in exercise, nutrition and metabolism in aging and the Center for Research on Aging University of Maryland, United States of America
Bas van de Goor
Retired volleyball player from the Netherlands, Olympic sportsman, diagnosed with type 1 diabetes, founder of the Bas van de Goor Foundation, aimed at ‘improving the quality of life for people with diabetes through sports’, the Netherlands
Jan Hazelzet
CMIO and Professor Health Care Quality and Outcome, Erasmus MC, the Netherlands
Darren Hodgson
Senior Principal Translational Scientist, Oncology iMED, AstraZeneca, United Kingdom. Part of DDResponse, a Collaborative Project funded by the 7th Framework Programme of the European Commission in the theme Health (2011-2015).
Albert Hofman
Professor in Epidemiology, Chairman Department of Epidemiology Erasmus MC, Sciences Director Netherlands Institute for Health Sciences (NIHES), The Netherlands; Professor of Epidemiology (adjunct) Harvard School of Public Health, Boston, United States of America
Hans Hofstraat
Vice-President and Member of the Health care Program Board at Philips Research, the Netherlands
Arfan Ikram
Associate professor, departments of Epidemiology, Radiology, Neurology
Principal Investigator Neuroepidemiology in the Rotterdam Study,
Erasmus MC, the Netherlands
John Ioannidis
C.F. Rehnborg Chair in Disease Prevention Stanford University, Professor of Medicine, Professor of Health Research and Policy, Director of the Stanford Prevention Research Center at Stanford University School of Medicine; Professor of Statistics (by courtesy) Stanford University School of Humanities and Sciences; director of the PhD program in Epidemiology and Clinical Research, Stanford University, United States of America
Floris Italianer
CEO Dutch Heart Foundation, the Netherlands; Board member European Heart Network; Board member World Heart Foundation; Advisory board member SA-Health Technical University Eindhoven; Patron ‘Stichting Hart in Actie’
Roland Kanaar
Professor of Molecular Radiation, Department Genetics, Department Radiation Oncology, Erasmus MC; Scientific co-founder of DNage, the Netherlands; Member of the scientific advisory board of the FIRC Institute of Molecular Oncology Foundation in Milan, Italy; member of editorial boards of a number of scientific journals including EMBO Journal and Molecular Cell; Member of the European Molecular Biology Organization.
Maryam Kavousi
Post-doctoral Researcher Department of Epidemiology Erasmus MC, the Netherlands; Working Group Leader International Consortium of Heart and Ageing Research in Genomic Epidemiology (CHARGE), Consortium on Health and Ageing: Network of Cohorts in Europe and the United States (CHANCES)
Ineke Klinge
Visiting Professor Institute of Gender in Medicine (GiM)/Charité, Universitätsmedizin, Berlin; Chair Horizon2020 Advisory Group on Gender
Menno Kok
Director, Medical Delta (a strategic alliance of top life sciences and medical technology), the Netherlands
Wessel Kraaij
Endowed Professor at Radboud University Nijmegen ( Institute for Computing and Information Sciences / Intelligent Systems / Information Foraging Lab), Principal Scientist Multimedia Technology, Netherlands Organisation for Applied Scientific Research (TNO), the Netherlands
Steven Lamberts
President of the Netherlands Diabetes Federation, Director International Affairs Erasmus MC; Member Supervisory Board University of Amsterdam; Member Supervisory Board Academic Medical Center (AMC), the Netherlands
Andy Last
Chief Operating Officer , Executive Vice President, Affimetrix, United States of America
Jan Lindemans
Emeritus Professor. Former head of the Department of Clinical Chemistry, including the central laboratories for clinical chemistry and general hematology Erasmus MC, the Netherlands
Volkert Lodwig
Head of Public Policy Roche Diagnostics, Germany. Managing Coordinator EIT Health.
Silke Mader
Chairwoman of the Executive Board, European Foundation for the Care of Newborn Infants (EFCNI), Germany
Ron Mathijssen
Professor in Individualized Oncological Pharmacotherapy, Department of Medical Oncology, Heading division of Translational Pharmacology, Erasmus MC, the Netherlands. Chair of the Dutch Pharmacology Oncology Group; a national collaboration to many patient-related factors influence the exposure to drugs involved in anti-cancer treatment.
Andrea Mensah
Healthcare Business Development Director, Health Sciences Global Business Unit Oracle, United Kingdom
Christianne van Nieuwenhoven
Plastic Surgeon, Handsurgeon, Erasmus MC, the Netherlands
Suzanne Pasmans
Professor of Paediatric Dermatology, dermatologist/immunologist, Erasmus MC, the Netherlands
Bruce Psaty
Professor, Department of Medicine, Professor Epidemiology, Adjunct Professor, Department of Health Services, Co-director, Cardiovascular Health Research Unit Senior Investigator, Group Health Research Institute, University of Washington, United States of America
Margaret Rees
Reader Emeritus in Reproductive Medicine, University of Oxford; Visiting Professor at University of Glasgow, Scotland; Visiting Professor at Karolinska Institute, Sweden; Visiting Professor at University of Turku, Finland; Adjunct Associate Professor at the Robert Wood Johnson Medical School, at Rutgers University, United States of America; University of Oxford St Hilda’s College, United Kingdom
Janine Roeters van Lennep
Internist, Vascular Medicine, Department of Internal Medicine, Erasmus MC; Member of the Foundation of first multidisciplinary out-patient clinic for long-term cardiovascular risk management in women with previous severe pro-eclampsia, the Netherlands
Liesbeth van Rossum
Internist-endocrinologist; Head of Obesity Center, adult division; Medical Coordinator of outpatient clinic of Endocrinology, Erasmus MC, the Netherlands
Francis Quint
Head of Innovation Quarter Capital (the regional economic development agency for the South Holland province), the Netherlands
Danny Sands
Co-Founder and Co-Chair, Society for Participatory Medicine; Assistant Clinical Professor of Medicine, Harvard Medical School, United States of America
Karin Schenk-Gustafsson
Professor of Cardiology, Senior consultant, Center for Gender Medicine Karolinska Institute, Sweden
Eric Sijbrands
Professor of Medical Oncology, Dean of the Faculty of Medicine Erasmus University, Vice Chairmain of the Board Erasmus MC, the Netherlands
Stefan Sleijfer
Professor in Medical Oncology, Head of Department of Medical Oncology, Erasmus MC; Board member of the Center for Personalized Cancer Treatment (CPCT – a Dutch national consortium aiming to improve personalized treatment for cancer patients by DNA sequencing metastatic tumor tissue); Member of the Scientific Board of the Dutch Cancer Society (KWF), the Netherlands
Peter van der Spek
Professor in Bioinformatics Erasmus MC, The Netherlands; Member of Strategic Development Partnership Oracle, USA; Member of Scientific Advisory Board New England Medical Center, Boston, United States of America
Wouter Spek
Director TIB Development, EuroBioForum Foundation, the Netherlands
Thijs Spigt
Director Erasmus MC Technology Transfer Office, the Netherlands
Miriam Sturkenboom
Professor of Pharmaco-epidemiology, Erasmus MC; Guest Lecturer Pharmacoepidemiology, State University of Milan; Scientific Manager of the Integrated Primary Care Information (IPCI) database, Department of Medical Informatics, Erasmus MC, the Netherlands
John Troup
Chief Science Officer & President Metaproteomics Research Division, Metagenics, United States of America
André Uitterlinden
Professor of Complex Genetics, Head Human Genotyping Facility Departments of Internal Medicine, Epidemiology and Clinical Chemistry Erasmus MC
Jaap Verweij
Professor of Medical Oncology, Dean of the Faculty of Medicine Erasmus University, Vice Chairmain of the Board Erasmus MC, Member of the Royal Netherlands Academy of Arts and Sciences, the Netherlands
Ron Voskuilen
Director, Rotterdam Partners, the Netherlands